| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2000-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9200155e033b2c0e4e7203671d091b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f39ffbbaac5172034cf029458561452c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7985c93c6bd551e0db32fd216132bf50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68585b1660fd79bc9db2960abe5bd25b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d9299c1ec2db65e1d51e923e016d9c |
| publicationDate |
2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2372339-A1 |
| titleOfInvention |
Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction |
| abstract |
The invention relates to pharmaceutical preparations that are used in a method for treating opiate addiction or opiate dependence, especially heroin dependence. The active substance used is preferably diamorphine and/or one of the pharmaceutically acceptable acid addition salts thereof. The invention also relates to a method for treating opiate dependence. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7824707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9101605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8628795-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616045-B2 |
| priorityDate |
1999-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |